Haemonetics Operating Expenses 2010-2024 | HAE

Haemonetics operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Haemonetics Annual Operating Expenses
(Millions of US $)
2024 $1,144
2023 $1,013
2022 $912
2021 $781
2020 $885
2019 $884
2018 $848
2017 $905
2016 $953
2015 $870
2014 $892
2013 $836
2012 $639
2011 $566
2010 $562
2009 $512
Haemonetics Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $294
2024-06-30 $296
2024-03-31 $313
2023-12-31 $290
2023-09-30 $283
2023-06-30 $258
2023-03-31 $269
2022-12-31 $262
2022-09-30 $251
2022-06-30 $231
2022-03-31 $246
2021-12-31 $224
2021-09-30 $215
2021-06-30 $227
2021-03-31 $246
2020-12-31 $200
2020-09-30 $151
2020-06-30 $184
2020-03-31 $212
2019-12-31 $218
2019-09-30 $203
2019-06-30 $252
2019-03-31 $225
2018-12-31 $219
2018-09-30 $216
2018-06-30 $224
2018-03-31 $219
2017-12-31 $233
2017-09-30 $201
2017-06-30 $194
2017-03-31 $286
2016-12-31 $207
2016-09-30 $195
2016-06-30 $218
2016-03-31 $248
2015-12-31 $295
2015-09-30 $201
2015-06-30 $210
2015-03-31 $215
2014-12-31 $214
2014-09-30 $215
2014-06-30 $226
2014-03-31 $229
2013-12-31 $224
2013-09-30 $212
2013-06-30 $226
2013-03-31 $232
2012-12-31 $232
2012-09-30 $208
2012-06-30 $163
2012-03-31 $166
2011-12-31 $166
2011-09-30 $161
2011-06-30 $147
2011-03-31 $141
2010-12-31 $148
2010-09-30 $138
2010-06-30 $139
2010-03-31 $165
2009-12-31 $139
2009-09-30 $130
2009-06-30 $128
2009-03-31 $134
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.938B $1.309B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $196.757B 25.10
Stryker (SYK) United States $136.750B 30.82
Boston Scientific (BSX) United States $131.731B 37.87
EssilorLuxottica (ESLOY) France $109.710B 0.00
Medtronic (MDT) Ireland $102.865B 15.28
Haleon (HLN) United Kingdom $42.732B 27.76
Lonza Group Ag (LZAGY) Switzerland $42.382B 0.00
GE HealthCare Technologies (GEHC) United States $35.810B 18.57
ResMed (RMD) United States $33.540B 27.56
Terumo (TRUMY) Japan $28.681B 40.51
Koninklijke Philips (PHG) Netherlands $23.480B 17.97
Zimmer Biomet Holdings (ZBH) United States $20.795B 13.24
Insulet (PODD) United States $18.017B 71.75
Baxter (BAX) United States $14.940B 9.72
Smith & Nephew SNATS (SNN) United Kingdom $10.667B 0.00
BellRing Brands (BRBR) United States $9.606B 38.65
Bio-Rad Laboratories (BIO) United States $9.131B 31.03
Demant (WILYY) Denmark $8.251B 0.00
Lantheus Holdings (LNTH) United States $6.174B 14.35
ICU Medical (ICUI) United States $3.868B 36.83
Prestige Consumer Healthcare (PBH) United States $3.840B 19.10
Perrigo (PRGO) Ireland $3.547B 10.44
Envista Holdings (NVST) United States $3.289B 24.50
QuidelOrtho (QDEL) United States $3.029B 19.50
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.863B 18.36
Neogen (NEOG) United States $2.587B 29.85
LeMaitre Vascular (LMAT) United States $2.057B 49.98
Green Thumb Industries (GTBIF) United States $1.724B 30.17
AtriCure (ATRC) United States $1.482B 0.00
InMode (INMD) Israel $1.424B 8.57
Maravai LifeSciences Holdings (MRVI) United States $1.386B 0.00
AdaptHealth (AHCO) United States $1.305B 9.33
BioLife Solutions (BLFS) United States $1.214B 0.00
Curaleaf Holdings (CURLF) Canada $1.066B 0.00
Owens & Minor (OMI) United States $0.991B 7.74
CeriBell (CBLL) United States $0.926B 0.00
Phibro Animal Health (PAHC) United States $0.840B 14.81
Evolus (EOLS) United States $0.704B 0.00
Capricor Therapeutics (CAPR) United States $0.680B 0.00
VAREX IMAGING (VREX) United States $0.594B 26.20
Omeros (OMER) United States $0.570B 0.00
Surmodics (SRDX) United States $0.567B 0.00
Verano Holdings (VRNOF) United States $0.502B 0.00
Cresco Labs (CRLBF) United States $0.463B 0.00
Quanterix (QTRX) United States $0.415B 0.00
Valneva SE (VALN) France $0.384B 0.00
ZimVie (ZIMV) United States $0.382B 32.16
Biote (BTMD) United States $0.328B 7.18
Viemed Healthcare (VMD) United States $0.317B 30.11
Canopy Growth (CGC) Canada $0.314B 0.00
Cerus (CERS) United States $0.292B 0.00
Sanara MedTech (SMTI) United States $0.289B 0.00
High Tide (HITI) Canada $0.269B 110.67
OraSure Technologies (OSUR) United States $0.264B 17.70
Zynex (ZYXI) United States $0.249B 52.07
Aurora Cannabis (ACB) Canada $0.247B 0.00
Organigram Holdings (OGI) Canada $0.209B 0.00
Utah Medical Products (UTMD) United States $0.208B 14.37
MacroGenics (MGNX) United States $0.207B 0.00
TerrAscend (TSNDF) Canada $0.205B 0.00
Sanuwave Health (SNWV) United States $0.188B 2.64
Brainsway (BWAY) Israel $0.180B 95.80
TriSalus Life Sciences (TLSI) United States $0.152B 0.00
Jin Medical (ZJYL) China $0.149B 0.00
FitLife Brands (FTLF) United States $0.148B 18.59
Quipt Home Medical (QIPT) United States $0.125B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.097B 0.00
Fonar (FONR) United States $0.096B 10.79
Veru (VERU) United States $0.095B 0.00
InterCure (INCR) Israel $0.072B 0.00
Rockwell Medical (RMTI) United States $0.072B 37.00
Jushi Holdings (JUSHF) United States $0.065B 0.00
Ayr Wellness (AYRWF) United States $0.060B 0.00
Apyx Medical (APYX) United States $0.059B 0.00
Exagen (XGN) United States $0.055B 0.00
Cytosorbents (CTSO) United States $0.050B 0.00
Modular Medical (MODD) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.047B 0.00
Safety Shot (SHOT) United States $0.045B 0.00
Allurion Technologies (ALUR) United States $0.027B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Nephros (NEPH) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.007B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Agape ATP (ATPC) $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.84
SNDL (SNDL) Canada $0.000B 0.00